Panacea Biotec Limited
Panacea Biotec Limited secured a ₹20.79 crore order from the Central Medical Services Society (CMSS) for supplying Diphtheria and Tetanus Vaccine (Td Vaccine). The supply will commence in September/October 2026 and conclude by November/December 2028.
Apr 11 2026 16:04:00
Panacea Biotec Limited
Panacea Biotec Limited secured a ₹20.79 crore order from the Central Medical Services Society (CMSS) for supplying Diphtheria and Tetanus Vaccine (Td Vaccine). The supply will commence in September/October 2026 and conclude by November/December 2028.
Apr 11 2026 16:04:00
Panacea Biotec Limited
Panacea Biotec received a Letter of Award worth ₹20.79 crore from the Central Medical Services Society. The contract is for the supply of Diphtheria and Tetanus Vaccine (Td Vaccine) for Adults and Adolescents, to be executed in tranches until November/December 2028.
Apr 11 2026 16:04:00
Panacea Biotec Ltd - 531349 - Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order
Panacea Biotec secured a ₹20.79 crore Letter of Award from Central Medical Services Society (CMSS) for Diphtheria and Tetanus Vaccine supply. This domestic order will be supplied in tranches from October 2026 to December 2028.
Apr 11 2026 16:04:00
Panacea Biotec Ltd - 531349 - Receipt Of Awards From The Presiding Officer Of Industrial Tribunal, Mohali
Panacea Biotec received four awards from an Industrial Tribunal on March 19, 2026, concerning labor disputes with workmen, including back wages and reinstatement. The company plans to appeal the awards and believes there will be no material adverse financial impact.
Apr 10 2026 16:04:00
Panacea Biotec Limited
Panacea Biotec received a rectified DCIT assessment order on April 06, 2026, setting its tax liability for AY 2016-17 as Nil. This action nullifies the previous ~₹10.23 crore demand, correcting errors from the initial order and removing adverse financial impact.
Apr 07 2026 12:04:00
Panacea Biotec Limited
Panacea Biotec's tax liability of ~₹45.71 crore for Assessment Year 2015-16 has been nullified. The Income Tax Department issued a rectified assessment order, correcting errors from the prior demand.
Apr 07 2026 12:04:00
Panacea Biotec Ltd - 531349 - Receipt Of Rectified Assessment Order For AY 2016-17
Panacea Biotec's tax liability for AY 2016-17 has been determined as nil by the DCIT, reversing an earlier demand of ₹10.23 crore. This rectification corrected errors including double disallowances and omission of set-off for brought-forward losses.
Apr 07 2026 11:04:00
Panacea Biotec Ltd - 531349 - Receipt Of Rectified Assessment Order For AY 2015-16
Panacea Biotec's tax liability for Assessment Year 2015-16 has been resolved to Nil following a rectified assessment order from the DCIT. This nullifies the previous demand of ~₹45.71 crore.
Apr 07 2026 11:04:00
Panacea Biotec Limited
Panacea Biotec: Mukul Gupta ceased to be a Non-Executive Independent Director effective March 31, 2026. His cessation is due to the completion of his tenure on the board.
Apr 01 2026 10:04:00
Read More